Therapiestrategien bei Kindern und Jugendlichen mit Langerhanszell Histiozytosen
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapiestrategien bei Kindern und Jugendlichen mit Langerhanszell
Histiozytosen
Authors
Keywords
-
Journal
KLINISCHE PADIATRIE
Volume -, Issue -, Pages -
Publisher
Georg Thieme Verlag KG
Online
2023-09-07
DOI
10.1055/a-2146-1395
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Paediatric Strategy Forum for Medicinal Product Development in Mitogen-Activated Protein Kinase (MAPK) pathway inhibitors. ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration
- (2022) Andrew DJ. Pearson et al. EUROPEAN JOURNAL OF CANCER
- Histiocytosis and the nervous system: from diagnosis to targeted therapies
- (2021) Fleur Cohen Aubart et al. NEURO-ONCOLOGY
- Response to mitogen‐activated protein kinase inhibition of neurodegeneration in Langerhans cell histiocytosis monitored by cerebrospinal fluid neurofilament light as a biomarker: a pilot study
- (2021) Jan‐Inge Henter et al. BRITISH JOURNAL OF HAEMATOLOGY
- Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA
- (2021) Dmitry Evseev et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Long‐term follow‐up of children with risk organ‐negative Langerhans cell histiocytosis after 2‐chlorodeoxyadenosine treatment
- (2020) Mohamed‐Aziz Barkaoui et al. BRITISH JOURNAL OF HAEMATOLOGY
- Indomethacin is an effective treatment in adults and children with bone Langerhans cell histiocytosis (LCH)
- (2020) Daniela De Benedittis et al. BRITISH JOURNAL OF HAEMATOLOGY
- Effectiveness and Safety of Dabrafenib in the Treatment of 20 Chinese Children with BRAFV600E-Mutated LCH
- (2020) Ying Yang et al. Cancer Research and Treatment
- Zoledronic acid for relapsed Langerhans cell histiocytosis with isolated skull bone lesion
- (2019) Ko Kudo et al. PEDIATRICS INTERNATIONAL
- Clinical responses and persistent BRAFV600E+ blood cells in children with LCH treated with MAPK pathway inhibition
- (2019) Olive S. Eckstein et al. BLOOD
- Progress towards molecular-based management of childhood Langerhans cell histiocytosis
- (2019) S. Héritier et al. ARCHIVES DE PEDIATRIE
- Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study
- (2019) Jean Donadieu et al. JOURNAL OF CLINICAL ONCOLOGY
- Nationwide retrospective review of hematopoietic stem cell transplantation in children with refractory Langerhans cell histiocytosis
- (2019) Kazuko Kudo et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- BISPHOSPHONATES IN LANGERHANS CELL HISTIOCYTOSIS: AN INTERNATIONAL RETROSPECTIVE CASE SERIES
- (2016) Deepak Chellapandian et al. Mediterranean Journal of Hematology and Infectious Diseases
- Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study
- (2015) J. Donadieu et al. BLOOD
- Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning
- (2015) Paul A. Veys et al. BRITISH JOURNAL OF HAEMATOLOGY
- Follow-up of pediatric patients treated by IVIG for Langerhans cell histiocytosis (LCH)-related neurodegenerative CNS disease
- (2014) Shinsaku Imashuku et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis
- (2013) H. Gadner et al. BLOOD
- Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease
- (2013) Stephen J. Simko et al. PEDIATRIC BLOOD & CANCER
- Nationwide survey of bisphosphonate therapy for children with reactivated Langerhans cell histiocytosis in Japan
- (2010) Akira Morimoto et al. PEDIATRIC BLOOD & CANCER
- 2′-chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the histiocyte society
- (2009) Sheila Weitzman et al. PEDIATRIC BLOOD & CANCER
- Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside
- (2009) Carl E. Allen et al. PEDIATRIC BLOOD & CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started